A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/202
A61K 31/70 (2006.01) A61K 9/127 (2006.01) A61K 47/48 (2006.01)
Patent
CA 1315684
ABSTRACT OF THE DISCLOSURE The present invention provides a method for preventing or treating disease caused by retroviruses, particularly human immunodeficiency virus. Liposomes are prepared containing phosphorylated derivatives of nucle- osides which act as chain-terminators of viral DNA. The phosphorylated nucleosides per se, without encapsulation in liposomes, do not readily enter cells. However, they are found to be effective if encapsulated in liposomes because they remain in liposomes longer, they do not escape easily from cells, and they constitute the active form for incorporation in viral DNA chains. When administered to a host, the liposomes are taken up by endocytic and phagocytic cells, which are important reservoirs of HIV infection. If coated with an appro- priate ligand, such as an immunoglobulin molecule, lipo- somes containing the phosphorylated nucleosides can be directed to phagocytic cells, CD4-positive cells, or infected host cells.
563582
Department Of Commerce
Gowling Lafleur Henderson Llp
LandOfFree
Anti-retroviral agents and delivery system for the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-retroviral agents and delivery system for the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-retroviral agents and delivery system for the same will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1320238